[1]
“Assesment of prevalence of Metabolic Syndrome in Patients on Atypical Antipsychotics: A Cross-Sectional Study in Erode”, Int. J. Res. Pharm. Sci. Technol., vol. 9, no. 3, Aug. 2026, doi: 10.33974/6ch5fm78.